References
- BologniaJLJorizzoJLRapiniRPDermatology13 ed New YorkMosby2012
- ChristophersEPsoriasis epidemiology and clinical spectrumClin Exp Dermatol20012631432011422182
- YoungMAldredgeLParkerPPsoriasis for the primary care practitionerJ Am Assoc Nurse Pract201729315717828233460
- RappSRFeldmanSRExumMLFleischerABJrReboussinDMPsoriasis causes as much disability as other major medical diseasesJ Am Acad Dermatol1999413 Pt 140140710459113
- WeissSCKimballABLiewehrDJBlauveltATurnerMLEmanuelEJQuantifying the harmful effect of psoriasis on health-related quality of lifeJ Am Acad Dermatol200247451251812271293
- GargAGladmanDRecognizing psoriatic arthritis in the dermatology clinicJ Am Acad Dermatol201063573374820950737
- TakeshitaJGrewalSLanganSMPsoriasis and comorbid diseases: epidemiologyJ Am Acad Dermatol201776337739028212759
- BarreaLNappiFDi SommaCEnvironmental risk factors in psoriasis: the point of view of the nutritionistInt J Environ Res Public Health2016137743
- BurnsTBrithnachSCoxNGrifithsCRook’s Textbook of Dermatology7th edNew YorkMosby2010
- BholeVMChoiHKBurnsLCDifferences in body mass index among individuals with PsA, psoriasis, RA and the general populationRheumatology (Oxford)201251355255622120603
- SchmittJMFordDEWork limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasisDermatology2006213210211016902286
- FarshchianMAnsarASobhanMAssociations between cardiovascular risk factors and psoriasis in IranClin Cosmet Investig Dermatol20158437442
- BardazziFBalestriRBaldiEAntonucciADe TommasoSPatriziACorrelation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapyDermatol Ther20102311419
- PrignanoFRicceriFPescitelliLComparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapiesCurr Med Res Opin20092592311231619635043
- EspositoMMazzottaASaracenoRSchipaniCChimentiSInfluence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasisInt J Immunopathol Pharmacol200922121922519309569
- FelmingPKraftJGulliverWPLyndeCThe relationship of obesity with the severity of psoriasis: a systematic reviewJ Cutan Med Surg201519545045626271963
- ArmstrongAWHarskampCTArmstrongEJThe association between psoriasis and obesity: a systematic review and meta-analysis of observational studiesNutr Diabetes20122e5410.1038/nutd.2012.2623208415
- NaldiLChatenoudLLinderDCigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control studyJ Invest Dermatol20051251616715982303
- HerronMDHinckleyMHoffmanMSImpact of obesity and smoking on psoriasis presentation and managementArch Dermatol2005141121527153416365253
- YosipovitchGDeVoreADawnAObesity and the skin: skin physiology and skin manifestations of obesityJ Am Acad Dermatol200756690191617504714
- World Health OrganizationObesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on ObesityGenevaWHO2000
- HammingaEAvan der LelyAJNeumannHAMThioHBChronic inflammation in psoriasis and obesity: implications for therapyMed Hypotheses200667476877316781085
- JensenPZachariaeCChristensenREffect of weight loss on the severity of psoriasis: a randomized clinical studyJAMA Dermatol2013149779580123752669
- WakkeeMThioHBPrensEPSijbrandsEJGNeumannHAUnfavorable cardiovascular risk profiles in untreated and treated psoriasis patientsAtherosclerosis200719011916942772
- MallbrisLGranathFHamstenAStahleMPsoriasis is associated with lipid abnormalities at the onset of skin diseaseJ Am Acad Dermatol200654461462116546581